Know Cancer

or
forgot password

Ultrasound Biomicroscopy for Monitoring Apoptosis in Lymphoma, Melanoma and Basal Cell Carcinoma Patients During Chemotherapy or Radiation Therapy


Phase 2
18 Years
N/A
Not Enrolling
Both
Lymphoma, Lymphoma, Non-Hodgkin, Melanoma, Carcinoma, Basal Cell

Thank you

Trial Information

Ultrasound Biomicroscopy for Monitoring Apoptosis in Lymphoma, Melanoma and Basal Cell Carcinoma Patients During Chemotherapy or Radiation Therapy


Inclusion Criteria:



- lymphoma patients with superficial lesions prior to starting chemotherapy or after
relapse of disease

- patients with superficial melanoma lesions

- patients with superficial basal cell carcinoma lesions

- Informed consent

Exclusion Criteria:

-

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Feasibility study of the use of Ultrasound Biomicroscopy for monitoring tumour response of lymphoma and melanoma patients to chemotheapy or radiation therapy.

Principal Investigator

Richard Tsang, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Princess Margaret Hospital, Canada

Authority:

Canada: Ethics Review Committee

Study ID:

UHN REB 01-0508-C

NCT ID:

NCT00188370

Start Date:

April 1999

Completion Date:

December 2004

Related Keywords:

  • Lymphoma
  • Lymphoma, Non-Hodgkin
  • Melanoma
  • Carcinoma, Basal Cell
  • Carcinoma
  • Carcinoma, Basal Cell
  • Lymphoma
  • Lymphoma, Non-Hodgkin
  • Melanoma

Name

Location